about
Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritisAnti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass.Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid ArthritisSustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.Second Hip Fracture: Incidence, Trends, and Predictors.Trends in osteoporotic hip fracture epidemiology over a 17-year period in a Spanish population: Alcorcón 1999-2015.Influence of patient personality in the treatment of rheumatoid arthritis.Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study.Reduction of Bone Mass in Women after Bone Marrow TransplantationWeather conditions and their effect on seasonality of incident osteoporotic hip fracturePOEMS syndrome with neuroarthropathy and nodular regenerative hyperplasia of the liverAntineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis[A study of bone mineral density in adult patients with cystic fibrosis]Reproducibility of metacarpophalangeal bone mass measurements obtained by dual-energy X-ray absorptiometry in healthy volunteers and patients with early arthritis[2011 Up-date of the consensus statement of the Spanish Society of Rheumatology on osteoporosis][Therapeutic compliance in osteoporosis in primary care][Septic arthritis and osteomyelitis caused by Pasteurella multocida: a new case]Estimated cutoff points for the 28-joint disease activity score based on C-reactive protein in a longitudinal register of early arthritis[Are calcium and vitamin D supplements for everyone?: Pro]Experience With the Use of Rituximab for the Treatment of Rheumatoid Arthritis in a Tertiary Hospital in Spain: RITAR StudyEast-west gradient in hip fracture incidence in Spain: how much can we explain by following the pattern of risk factors?Mortality after osteoporotic hip fracture: incidence, trends, and associated factorsHyperlipoproteinaemia(a) in patients with spondyloarthritis: results of the Cardiovascular in Rheumatology (CARMA) projectReproducibility of Metacarpal Bone Mineral Density Measurements Obtained by Dual-Energy X-Ray Absorptiometry in Healthy Volunteers and Patients With Early ArthritisOrthopedic Surgery in Rheumatoid Arthritis: Results from the Spanish National Registry of Hospitalized Patients over 17 Years
P50
Q28740658-82A42C4E-3AFD-41F4-BC89-AFDE76187538Q31167745-757C20CE-3F71-4C5B-98D2-6D8A9A954681Q33923332-BE1C034A-0C3C-4A45-928E-10DA293075E3Q36125286-A923CE99-5BC2-493F-B835-A0245522417EQ39514753-F33E7E15-F139-4D4F-B5F2-DBD9BAC73981Q47437950-6559007A-AF26-477B-8E8D-623A437649CAQ47626392-DCACB888-D095-4329-89FF-A21826A18E33Q53700303-4DED6C3C-27F4-4ED7-8C81-44BB10E0DD68Q55405093-FD18E358-0076-4889-AB16-1E7C4C226994Q56967023-DB72B966-B6CD-47EE-98E9-DC080BA60305Q57106907-28413710-0BF6-46E4-9AAB-F65B7663546AQ72392485-717877D8-7B3D-4F00-9833-0CD0684001D5Q73165911-3EA3B7A4-E38C-49A8-9479-9E9F8F19EC94Q80260731-BA10DFC7-5487-4353-A51A-8B2C0D1D4FD3Q80490144-3B54C555-A608-41C1-A96E-C72FFA282E6BQ82479846-9DA0BF1A-4C2F-4DE4-8517-C4350D817B14Q82827732-5D553C8B-7FE5-473B-95A7-AD723597DA83Q83868568-5AFB2FAA-2B37-48DF-B22F-F3AF0E3E3350Q84230843-227014BF-D66F-41F7-8AD9-78FE15954520Q84956121-6CCF533A-1221-46E0-A74F-F18F268CE1F2Q89997443-A920E37A-887B-4C81-B571-DE8C831D7F16Q91480555-031C582F-9681-4735-9758-0B721848C8BFQ91614866-A974BE08-DDC3-4D9C-A5CC-4DA637CAEA7BQ91788981-A6F93B26-A377-46FC-9D97-E65BAEFD63D9Q92610549-D4CB0751-FF43-438E-BB3D-625496972112Q92774513-8BE9989B-A656-479C-BA0E-3B954B9C6901
P50
description
researcher
@en
wetenschapper
@nl
name
A García-Vadillo
@en
A García-Vadillo
@nl
type
label
A García-Vadillo
@en
A García-Vadillo
@nl
prefLabel
A García-Vadillo
@en
A García-Vadillo
@nl
P106
P31
P496
0000-0003-3262-8364